1. Title 21, Code of Federal Regulations, Part 211. Available: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211.
2. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use. Article 8. Available: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/directive-2001/83/ec-european-parliament-council-6-november-2001-community-code-relating-medicinal-products-human-use_en.pdf
3. The History of Cellular Therapies;Crees,2022
4. Gottlieb, S, Marks, P. Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies. U.S. Food and Drug Administration. January 15, 2019. Available: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-and-peter-marks-md-phd-director-center-biologics
5. Driving the next wave of innovation in CAR-T cell therapies;Nam,2019